Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-10-07 07:45 am Sale | 2022-10-04 | 13D | Crescent Biopharma, Inc. CBIO | SINGER JULIAN D. | 722 3.440% | -4,976 (-87.34%) | Filing History |
| 2022-08-19 4:30 pm Unchanged | 2022-08-18 | 13D | Crescent Biopharma, Inc. CBIO | SINGER JULIAN D. | 5,698 7.100% | 0 (Unchanged) | Filing History |
| 2022-08-03 4:17 pm Unchanged | 2022-08-03 | 13D | Crescent Biopharma, Inc. CBIO | SINGER JULIAN D. | 5,698 7.100% | 0 (Unchanged) | Filing History |
| 2022-07-22 2:21 pm Purchase | 2022-07-20 | 13D | Crescent Biopharma, Inc. CBIO | SINGER JULIAN D. | 5,698 7.100% | 590 (+11.54%) | Filing History |
| 2022-06-17 4:30 pm Unchanged | 2022-06-15 | 13D | Crescent Biopharma, Inc. CBIO | SINGER JULIAN D. | 5,108 6.400% | 0 (Unchanged) | Filing History |
| 2022-05-25 5:01 pm Purchase | 2022-05-24 | 13D | Crescent Biopharma, Inc. CBIO | SINGER JULIAN D. | 5,108 6.400% | 1,781 (+53.51%) | Filing History |
| 2022-05-10 4:58 pm Unchanged | 2022-05-09 | 13D | Crescent Biopharma, Inc. CBIO | SINGER JULIAN D. | 3,328 4.170% | 0 (Unchanged) | Filing History |
| 2022-05-02 5:27 pm Unchanged | 2022-04-28 | 13D | Crescent Biopharma, Inc. CBIO | SINGER JULIAN D. | 3,328 4.170% | 0 (Unchanged) | Filing History |
| 2022-04-21 1:09 pm Unchanged | 2022-04-20 | 13D | Crescent Biopharma, Inc. CBIO | SINGER JULIAN D. | 3,328 4.170% | 0 (Unchanged) | Filing History |
| 2022-03-16 08:00 am Unchanged | 2022-03-15 | 13D | Crescent Biopharma, Inc. CBIO | SINGER JULIAN D. | 3,328 4.180% | 0 (Unchanged) | Filing History |
| 2022-03-07 3:53 pm Unchanged | 2022-03-04 | 13D | Crescent Biopharma, Inc. CBIO | SINGER JULIAN D. | 3,328 4.180% | 0 (Unchanged) | Filing History |
| 2022-02-28 1:16 pm Purchase | 2022-02-24 | 13D | Crescent Biopharma, Inc. CBIO | SINGER JULIAN D. | 3,328 4.180% | 182 (+5.78%) | Filing History |
| 2022-02-22 7:04 pm Purchase | 2022-02-22 | 13D | Crescent Biopharma, Inc. CBIO | SINGER JULIAN D. | 3,146 3.950% | 1,167 (+58.99%) | Filing History |
| 2022-01-27 11:56 am Unchanged | 2022-01-26 | 13D | Crescent Biopharma, Inc. CBIO | SINGER JULIAN D. | 1,979 2.480% | 0 (Unchanged) | Filing History |
| 2022-01-05 5:29 pm Purchase | 2022-01-04 | 13D | Crescent Biopharma, Inc. CBIO | SINGER JULIAN D. | 1,979 2.480% | 304 (+18.17%) | Filing History |
| 2021-10-25 9:08 pm Purchase | 2021-10-25 | 13D | Crescent Biopharma, Inc. CBIO | SINGER JULIAN D. | 1,674 2.110% | 663 (+65.59%) | Filing History |
| 2021-03-19 6:51 pm Sale | 2021-03-17 | 13G | HC2 Holdings, Inc. HCHC | SINGER JULIAN D. | 0 0.000% | -3,262,514 (Position Closed) | Filing History |